Rep. Robert Bresnahan, Jr. Sells Agilent Technologies, Inc. (NYSE:A) Shares

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Agilent Technologies, Inc. NYSE: A. In a filing disclosed on April 28th, the Representative disclosed that they had sold between $1,001 and $15,000 in Agilent Technologies stock on April 8th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of DexCom NASDAQ: DXCM on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Invesco NYSE: IVZ on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Generac NYSE: GNRC on 4/8/2025.
• Sold $15,001 - $50,000 in shares of Occidental Petroleum NYSE: OXY on 4/8/2025.
• Sold $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 4/8/2025.
• Sold $1,001 - $15,000 in shares of QUALCOMM NASDAQ: QCOM on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Best Buy NYSE: BBY on 4/8/2025.
• Sold $1,001 - $15,000 in shares of EOG Resources NYSE: EOG on 4/8/2025.
• Sold $1,001 - $15,000 in shares of CSX NASDAQ: CSX on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Valero Energy NYSE: VLO on 4/8/2025.

Agilent Technologies Price Performance

A stock traded up $0.22 during mid-day trading on Monday, reaching $108.85. 85,670 shares of the company's stock were exchanged, compared to its average volume of 1,876,366. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. The company has a market cap of $31.03 billion, a price-to-earnings ratio of 25.00, a price-to-earnings-growth ratio of 3.06 and a beta of 1.27. The stock's 50 day moving average is $113.57 and its 200 day moving average is $129.71. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, research analysts expect that Agilent Technologies, Inc. will post 5.54 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st were given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date was Tuesday, April 1st. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on A shares. Barclays decreased their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Jefferies Financial Group cut their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research note on Monday, April 21st. Robert W. Baird lowered their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a report on Thursday, February 27th. TD Cowen boosted their price target on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Finally, Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $143.00.

Hedge Funds Weigh In On Agilent Technologies

Institutional investors have recently added to or reduced their stakes in the stock. CKW Financial Group increased its position in Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after purchasing an additional 100 shares during the period. Global X Japan Co. Ltd. increased its position in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after purchasing an additional 116 shares during the last quarter. Redwood Park Advisors LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at about $27,000. Lee Danner & Bass Inc. purchased a new stake in Agilent Technologies during the 4th quarter worth $29,000. Finally, Whipplewood Advisors LLC boosted its holdings in Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after acquiring an additional 186 shares during the period.

Insider Buying and Selling at Agilent Technologies

In other news, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now directly owns 35,737 shares of the company's stock, valued at $4,161,931.02. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.